rs9786232 (TTTY14): Paternal Lineage Marker

What each genotype means

Genomic Context and the Y Chromosome

The single-nucleotide polymorphism rs9786232 resides on the human Y chromosome (chrY) and is mapped within the non-recombining male-specific region. In phylogenetic nomenclature, it is frequently designated as P233. Because the male-specific region of chromosome Y is inherited directly from father to son without reciprocal homologous recombination, mutations that arise here remain linked across generations, accumulating in a stepwise phylogenetic tree. The variant represents a transition between reference and derived alleles that precisely demarcates sub-branches of human paternal lineages. Because biological males carry only one Y chromosome, individuals who possess this chromosome have a single hemizygous allele at this site rather than the paired diploid genotypes seen on autosomes.

Role of the TTTY14 Locus

The rs9786232 variant maps to the genomic region of TTTY14 (Testis Expressed Transcript, Y-Linked 14). TTTY14 belongs to the class of long non-protein-coding RNAs (lncRNAs) and is largely characterized by transcript expression in male reproductive tissues and the central nervous system. Functional bioinformatics models predict that TTTY14 transcripts may participate in pre-mRNA 5'-splice site recognition and interact with the U1 small nuclear ribonucleoprotein (snRNP) complex involved in general spliceosomal processing. While several exploratory transcriptomic studies have monitored non-coding RNAs across male tissues, the presence of standard sequence variations like rs9786232 within TTTY14 has not been demonstrated to cause monogenic disease or disrupt primary cellular function.

Lineage Classification and Evidence Strength

In human population genetics and phylogenetic classification, rs9786232 is recognized for defining paternal haplogroup R1 (R-M173/P233), branching off from the ancestral haplogroup R. Research cataloging the variant demonstrates strong evidentiary support for its role in tracking ancient paternal population migrations. Conversely, its association with clinical disease phenotypes, pharmacological responses, or metabolic traits has limited to no evidence. Major genomic curation databases like ClinVar do not report pathogenic or disease-causing classifications for this locus. As such, the evidence supporting rs9786232 is robust as a population history marker but strictly non-clinical in nature.

Distribution Across Global Populations

Because rs9786232 is directly linked to the expansion of Y-chromosomal haplogroup R1, its distribution matches the geographic spread of this paternal lineage. The derived state of this variant is observed at high frequencies among male populations originating in Europe, the Near East, and South Asia, where descendant sub-clades (such as R1a and R1b) expanded rapidly following late-Pleistocene and early-Holocene migrations. In contrast, it is generally absent or found at negligible frequencies in paternal lineages native to Sub-Saharan Africa, East Asia, and indigenous populations of the Americas that belong to divergent basal Y-haplogroups. Biological females do not carry the Y chromosome and therefore lack this marker entirely.

Interpreting Your Results

Discovering an allele for rs9786232 in a personal genetic test provides insight into paternal ancestry, clarifying an individual's place within the global Y-DNA phylogenetic tree. It is important to emphasize what this information cannot do: it does not provide insight into general health status, disease predisposition, medication metabolism, or physical traits. Because this variant represents benign neutral variation reflecting population history, it should never be interpreted as a medical diagnosis or used to make clinical decisions. Individuals seeking to explore genealogical implications can view this marker as a signpost of deep paternal lineage.

Frequently asked questions

Sources & further reading